Alpha PRO Tech LTD income statement
In fiscal 2025, Alpha PRO Tech LTD reported revenue of $59.1m, up 2.3% on the year before, operating income of $3.8m (a 6.5% margin) and net income of $3.5m, or $0.33 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42 | 39 | 41 | 44 | 48 | 45 | 46 | 44 | 47 | 47 | 103 | 69 | 62 | 61 | 58 | 59 | 62 |
| Cost of revenue | — | — | — | — | — | — | — | 27 | 29 | 30 | 52 | 43 | 40 | 38 | 35 | 37 | 38 |
| Gross profit | 16 | 14 | 14 | 16 | 17 | 16 | 17 | 17 | 18 | 17 | 50 | 25 | 22 | 23 | 23 | 23 | 24 |
| Research and development | — | — | — | — | — | — | 0 | 0 | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 14 | 12 | 13 | 13 | 14 | 14 | 13 | 14 | 13 | 13 | 18 | 17 | 16 | 18 | 19 | 18 | 18 |
| Operating income | 2 | 1 | 1 | 2 | 3 | 1 | 4 | 3 | 4 | 3 | 32 | 8 | 5 | 4 | 3 | 4 | 5 |
| Income tax | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 5 | 2 | 1 | 1 | 1 | 1 | 1 |
| Net income | 1 | 1 | 1 | 2 | 3 | 1 | 3 | 3 | 4 | 3 | 27 | 7 | 3 | 4 | 4 | 4 | 4 |
| Diluted EPS | $0.06 | $0.04 | $0.05 | $0.11 | $0.15 | $0.06 | $0.19 | $0.18 | $0.26 | $0.23 | $1.92 | $0.50 | $0.26 | $0.35 | $0.35 | $0.33 | $0.41 |
| Diluted shares (average) | 23m | 22m | 21m | 19m | 19m | 18m | 17m | 15m | 14m | 13m | 14m | 13m | 13m | 12m | 11m | 11m | 10m |
| EBITDA | 3 | 2 | 2 | 3 | 4 | 2 | 4 | 3 | 4 | 4 | 32 | 9 | 5 | 5 | 4 | 5 | 6 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14 | 14 | 14 | 17 | 15 | 14 | 15 | 19 |
| Cost of revenue | 9 | 9 | 8 | 11 | 9 | 9 | 9 | 12 |
| Gross profit | 5 | 5 | 5 | 6 | 6 | 5 | 6 | 7 |
| Selling, general and administrative | 5 | 4 | 5 | 5 | 5 | 4 | 5 | 5 |
| Operating income | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 2 |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Net income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Diluted EPS | $0.08 | $0.07 | $0.06 | $0.12 | $0.09 | $0.06 | $0.07 | $0.18 |
| EBITDA | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 |
Compare with peers
- Cvrx, Inc. income statement
- Lensar, Inc. income statement
- Apyx Medical Corp income statement
- Electromed, Inc. income statement
- Iridex Corp income statement
Head to head: APT vs CVRXAPT vs LNSRAPT vs APYX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies